ICT Media

ICT budget and staffing trends in Pharmaceuticals - Enterprise ICT investment plans

  • KAB110133
  • 32 Pages
  • November 2013
  • ICT Media
Synopsis
This report presents the findings from a survey of 102 pharmaceutical companies regarding their Information & Communications Technology (ICT) budgets and staff allocation. The survey investigates how pharmaceutical companies currently allocate their ICT budgets across the core areas of ICT spend, namely hardware, software, IT services, communications and consulting.
Scope
Understand how ICT budgets are set to change in 2013 in terms of their overall size.

Appreciate how budgets are allocated across the core elements of ICT spend, including hardware, software, services, communications and consulting.

Learn how ICT money is being spent in areas such as the data centre, applications, IT management and the network.

Establish how IT staff are typically allocated within pharmaceuticals industry.

Gain insight into with whom pharmaceutical companies plan to spend their ICT money.
Summary
Why was the report written?
In order to provide a depth of insight into ICT vendors and service providers potential customers.

What is the current market landscape and what is changing?
Kables survey shows that overall ICT spending in the pharmaceutical sector is set to increase in 2013 compared to 2012, with the highest proportion of the average ICT budget being allocated to hardware, followed by software and IT services.

What are the key drivers behind recent market changes?
Emerging technology trends such as thin client computing devices, analytical & business intelligence tools, and cloud computing services are heavily influencing ICT investments in the sector. Increasing compliance regulations are also compelling pharmaceutical companies to invest in IT security solutions.

What makes this report unique and essential to read?
Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT Budgets. Very few IT analyst houses will have interviewed 100+ ICT decision makers in the pharmaceuticals industry in H2 2012.
ReasonsToBuy
In order to store and manage the rising volume of clinical data, pharmaceutical companies have been making significant investments in their data centres in 2013.

Pharmaceutical companies are allocating a major portion of their ICT budgets to core ICT infrastructure in order to improve their business processes to respond well in this highly regulated and challenging market place.

With an increasingly geographically dispersed employee base, pharmaceutical companies are keen to invest in network and communications technologies.

The survey also shows that pharmaceutical companies are spending a noticeable portion of their IT services budgets on security & privacy services, in order to maintain a competitive edge amidst increasing regulatory demands for data protection.

The proportional spend with technology (product) vendors and specialist outsourcers are both likely to drop by in 2013 compared to 2012, as companies look to bring more of their ICT investments in-house.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Telematics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Telematics by the synonym itself defines the integration of telecommunications and information and communications technologies abruptly called as informatics. It can be simply the technology of transmitting, receiving, sending and ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bernfield and colleagues ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Drug Testing Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Tissue Engineering and Regeneration Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Tissue engineering is developed from the field of biomaterials development and refers to the practice of combining cells or tissues with biologically active molecules into functional tissues. They are mainly ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Biopsy Devises Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

2017 © Copyright Big Market Research

View Pricing >>